Jul/Aug 2009 - Hormone Replacement Therapy

Purchase or view individual articles by selecting the article in the table below...

Individual Articles - Jul/Aug 2009 - Hormone Replacement Therapy

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Jul/Aug 2009 Pg. 268	PreScription: Trust Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 270-275	The Physiologic Role and Use of Estriol Author(s): Paoletti Jim E
Jul/Aug 2009 Pg. 276-279	Hormone Treatment Options for Males: What to Do for Men with Low Testosterone Author(s): Biundo Bruce
Jul/Aug 2009 Pg. 280-288	Saliva Tests, Part 1: Clinical Use, Elements of Testing, and Guidelines for Posttreatment Interpretation Author(s): Kells John, Dollbaum Charles M
Jul/Aug 2009 Pg. 290-294	Preventing Nonmicrobiologic Airborne Contamination in the Compounding Pharmacy: Ensuring a Safe Environment for Compounders, Staff, and Clients Author(s): Mixon Bill, Ille Gary
Jul/Aug 2009 Pg. 296-299	Compounding Naltrexone for the Treatment of Autism Author(s): Wynn Tom, Brunetti Sarah
Jul/Aug 2009 Pg. 300-310	Preparing Nonsterile and Sterile Hazardous Compounds in an Institutional Setting Author(s): McElhiney Linda F
Jul/Aug 2009 Pg. 311-312	Optimizing Your Website: Search Engine Optimization, Pay Per Click, Email Marketing Author(s): Storey Patricia L
Jul/Aug 2009 Pg. 314-317	Poster Presentation Report: Safety of Maternal Testosterone Therapy During Breast Feeding Author(s): Glaser Rebecca L, Newman Mark, Parsons Melanie, Zava David, Glaser-Garbrick Daniel
Jul/Aug 2009 Pg. 318-320	Quality-Control Analytical Methods: Quality Control, Quality Assurance, and Quality Improvement--What is the Difference and Why Should Compounding Pharmacies Care? Author(s): Cabaleiro Joe
Jul/Aug 2009 Pg. 322-329	Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued) Author(s): Okeke Claudia C, Allen Loyd V Jr
Jul/Aug 2009 Pg. 330	Calculations Author(s): Stockton Shelly J
Jul/Aug 2009 Pg. 332	Alcohol-based Carbomer Gel Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 333	Benzoyl Peroxide 10% Gel Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 334	Clindamycin 100-mg Vaginal Suppositories Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 335	Dexamethasone and Furosemide Injection Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 336	Instant Voice Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 337	Moxifloxacin 20-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 338	Mupirocin 1% (20-mg) Vaginal Suppository Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 339	Riley Butt Cream Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 340	Selegiline Hydrochloride 1-mg/0.05-mL Oral Suspension in Oil Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 341	Trolamine Oleate Otic Solution Author(s): Allen Loyd V Jr
Jul/Aug 2009 Pg. 342-344	Quality of Progesterone Suppositories Prepared by FIRST-Progesterone VGS 50 Kit or Traditional Compounding Method: In Vitro Comparison Author(s): Chauhan Harsh, Atef Eman
Jul/Aug 2009 Pg. 345-349	Women's Perspective on Progesterone: A Qualitative Study Conducted in Australia Author(s): Spark M Joy, Dunn Rebecca A, Houlahan Kelli L
Jul/Aug 2009 Pg. 350-351	PostScription: Compounding Pharmacy in Puerto Rico Author(s): Lopez Marisol